Regeneron Pharmaceuticals, Inc. (REGN)

NASDAQ: REGN · Real-Time Price · USD

749.41

-1.16 (-0.15%)

At close: Apr 20, 2026, 4:00 PM EDT

755.18

+5.77 (0.77%)

After-hours: Apr 20, 2026, 4:25 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Net Product Sales Revenue	6.31B	7.63B
Net Product Sales Revenue Growth	-17.30%	7.79%
Total Collaboration Revenue	7.33B	6.06B
Total Collaboration Revenue Growth	21.02%	10.08%
Other Product Revenue	702.60M	515.00M
Other Product Revenue Growth	36.43%	-3.94%
Revenue (Total)	14.34B	14.20B
Revenue (Total) Growth	0.99%	8.27%

Updated Jan 30, 2026. Data Source: Fiscal.ai.